Great West Life Stock – Price, Dividend and 2025 Outlook
Great-West Lifeco Inc. stands as one of Canada’s largest insurance and financial services providers, trading on the Toronto Stock Exchange under the ticker GWO. The company has attracted significant investor attention following a robust 25% price appreciation over the past twelve months, buoyed by strong earnings growth and attractive dividend yields exceeding 4%.
With a market capitalization ranging between 53 and 56 billion CAD, Great-West Lifeco operates as a cornerstone holding for many Canadian portfolios. The stock currently trades in the 57 to 66 CAD range, showing resilience amid broader market volatility.
This comprehensive overview examines the essential metrics, analyst perspectives, and financial fundamentals that investors need to evaluate when considering GWO.TO for their portfolios.
What is the Current Great-West Lifeco Stock Price and Key Metrics?
57-66 CAD
49.54-68.56 CAD
4.25%
~53-56B CAD
- 12-month growth of approximately 25% outperforms many sector peers
- Low beta coefficient between 0.06 and 0.72 indicates reduced volatility
- Revenue increased 11.19% year-over-year to 34.74 billion CAD in 2024
- Net income surged 43.90% to 3.94 billion CAD
- Price-to-earnings ratio sits at moderate 14.22-14.87
- Shares outstanding total approximately 906-931 million
| Metric | Value |
|---|---|
| Ticker | GWO |
| Exchange | TSX |
| Sector | Financial Services |
| P/E Ratio (ttm) | 14.22-14.87 |
| EPS (ttm) | 4.01 CAD |
| Shares Outstanding | ~906-931 million |
| Beta | 0.06-0.72 |
| Forward P/E | 11.66 |
Current market data shows GWO trading between 57 and 66 CAD according to StockAnalysis, with market capitalization figures corroborated by Morningstar.
Is Great-West Lifeco Stock a Good Buy? Analyst Ratings and Outlook
Analyst consensus positions Great-West Lifeco with price targets spanning from 52.00 CAD to 63.00 CAD, suggesting modest upside potential from current levels. The narrow spread between minimum and maximum estimates indicates general agreement on the stock’s fair valuation.
Technical Momentum Indicators
Recent chart patterns reveal a double bottom reversal formation that has successfully broken through key resistance levels. The stock has crossed above its 200-day moving average, signaling a potential shift from bearish to bullish sentiment. The Relative Strength Index registers at 70.54, indicating strong upward momentum without immediate oversold conditions.
2025 Price Projections
According to Trading Economics modeling, GWO may reach 57.89 CAD by Q4 2025, with a one-year outlook targeting 53.98 CAD based on global macroeconomic variables and aggregated analyst expectations.
Current estimates from TradingView place the maximum price target at 63.00 CAD and the minimum at 52.00 CAD, reflecting a cautiously optimistic view of the stock’s near-term trajectory.
What is the Dividend Yield and Financial Performance?
Great-West Lifeco maintains its reputation as an income-generating investment with a dividend yield of 4.25%, distributing 2.44 CAD per share annually. This yield substantially exceeds typical savings rates, attracting retirees and dividend-focused portfolio managers.
2024 Earnings Results
The company’s 2024 fiscal year demonstrated impressive operational growth. Revenue climbed to 34.74 billion CAD, marking an 11.19% increase from the prior year’s 31.24 billion. Net income accelerated even faster, jumping 43.90% to reach 3.94 billion CAD.
Trailing Twelve-Month Metrics
On a trailing twelve-month basis, Great-West Lifeco generated 35.08 billion CAD in revenue alongside 3.73 billion CAD in net income. Earnings per share for the period settled at 4.01 CAD, supporting the current valuation multiples.
Data from Barchart indicates the stock trades at 14.22 to 14.87 times trailing earnings, with a forward P/E of 11.66 suggesting analysts anticipate continued earnings growth. Price-to-book ratio stands at 2.05, while price-to-sales hovers between 1.39 and 1.53.
How Has Great-West Lifeco Stock Performed Historically?
Historical data from Investing.com reveals GWO’s 52-week trading corridor between 49.54 CAD and 68.56 CAD, with the upper bound testing levels not seen in recent years. The approximately 25% annual gain outperformed many peer financial services stocks during the same period.
Beta measurements between 0.06 and 0.72 confirm the stock’s defensive characteristics, meaning shares move significantly less than the broader TSX Composite during market fluctuations. This stability has historically appealed to conservative investors seeking wealth preservation alongside modest growth.
While the beta suggests low volatility relative to the market, investors should note that financial services stocks face sector-specific risks including interest rate sensitivity and regulatory changes that may not be fully captured by broad market correlation metrics.
What is the Timeline of Great-West Lifeco’s Market Evolution?
- Initial Public Listing: Great-West Lifeco established its TSX presence, building a market capitalization that would eventually reach the current 53-56 billion CAD range.
- Strategic Expansion: Major acquisitions expanded the company’s asset management and insurance operations across North America and Europe.
- Dividend Aristocrat Status: The company established its track record of consistent dividend payments, reaching the current 4.25% yield level with 2.44 CAD annual distributions.
- 2024 Earnings Surge: Fourth quarter 2024 results revealed 43.90% net income growth to 3.94 billion CAD, marking one of the strongest years in recent history.
- Technical Breakthrough: Recent months saw the stock break above 68.56 CAD resistance levels before settling into current trading ranges.
What Remains Certain and Uncertain About GWO’s Future?
Established Facts
- Market capitalization definitively sits between 53-56 billion CAD
- 2024 revenue of 34.74 billion CAD verified in annual filings
- Dividend yield of 4.25% currently distributed quarterly
- 906-931 million shares outstanding
- P/E ratio range of 14.22-14.87 based on ttm earnings
Uncertain Projections
- 2025 price targets vary between 52.00 and 63.00 CAD
- Trading Economics forecasts suggest potential decline to 53.98 CAD within one year
- Interest rate environment impact on insurance margins remains unclear
- Regulatory capital requirement changes under review
- Macroeconomic recession risks not fully priced into current valuations
Who Owns Great-West Lifeco and What is Its Strategic Position?
Great-West Lifeco operates as a subsidiary of Power Corporation of Canada, which maintains controlling interest through its ownership structure. This relationship provides access to additional capital resources and strategic synergies within the broader Power group of companies.
The company functions within the financial services sector, competing directly against other major Canadian insurers while maintaining significant operations in the United States and Europe. Its business model emphasizes life insurance, retirement services, and asset management, sectors that typically benefit from aging demographics and increasing retirement planning needs. For those seeking assistance, Servei d’atenció al client de RBC can provide further details.
Those navigating Step-by-Step health insurance renewal guide processes may find parallels in how Great-West Lifeco manages policy renewals and coverage transitions across its insurance portfolios.
What Are Market Analysts Reporting About Great-West Lifeco?
Great-West Lifeco demonstrates robust fundamentals with a 25% annual gain supported by 43% net income growth, positioning it favorably among Canadian financial stocks despite macroeconomic headwinds.
— Market data aggregation from TradingView and StockAnalysis
The double bottom reversal pattern breaking above the 200-day moving average suggests institutional accumulation and potential continued upward momentum for GWO shares.
— Technical analysis consensus from TradingView
Should Investors Consider Great-West Lifeco Stock for 2025?
Great-West Lifeco presents a compelling case for income-focused investors seeking defensive financial sector exposure, combining a 4.25% dividend yield with reasonable valuation multiples around 14 times earnings. While analyst price targets suggest limited near-term upside between 52 and 63 CAD, the company’s strong 2024 earnings growth and low volatility profile support long-term holding strategies. Those evaluating pharmaceutical investments like the New cholesterol lowering pill alongside traditional financial stocks should note GWO’s distinct risk-return characteristics within a diversified portfolio.
Frequently Asked Questions About Great-West Lifeco Stock
What is the ticker symbol for Great-West Lifeco?
Great-West Lifeco trades on the Toronto Stock Exchange under the ticker symbol GWO.
How can investors buy Great-West Lifeco stock?
Investors can purchase GWO shares through any brokerage account that provides access to Toronto Stock Exchange listings, including major Canadian banks and online trading platforms.
What sector does Great-West Lifeco operate in?
The company operates within the financial services sector, specifically focusing on life insurance, retirement services, and asset management.
What is the current dividend yield?
Great-West Lifeco currently offers a dividend yield of approximately 4.25%, paying 2.44 CAD per share annually.
How many shares are outstanding?
The company has approximately 906 to 931 million shares outstanding.
What is the 52-week trading range?
GWO has traded between 49.54 CAD and 68.56 CAD over the past 52 weeks.
Who owns Great-West Lifeco?
Power Corporation of Canada maintains controlling ownership of Great-West Lifeco, operating it as a subsidiary within their financial services portfolio.
More related posts
Sea Salts Guide: Health Benefits, Types, Comparisons
Chace Crawford: Biography, Relationships, and Career Facts
Shaun of the Dead – Everything You Need to Know About the Film
Ted Kennedy: Conviction, Death, and Political Legacy
Rudy Gobert: Biography, Stats, Salary, Controversies
William Hurt: Oscar Winner, Co-Star Feuds, and Cancer Battle
COVID-19 Razor Blade Sore Throat: Symptoms, Treatment & Duration
Jude Law: Biography, Children, and Career Facts
